Usefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study
Nutrients · 03.07.2024 · 16 (13) · 2126
DOI: 10.3390/nu16132126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 03.07.2024. Verfasst von Koichi Okamoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Digestive Surgery, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinadamachi, Kahoku 920-0293, Ishikawa, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Arginine, Esophagectomy, Valerates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A useful perioperative nutritional therapy for highly invasive esophageal cancer surgical cases needs to be developed. We clarified the usefulness of amino-acid-enriched nutritional therapy using glutamine (Gln)/arginine (Arg)/calcium β-hydroxy-β-methylbutyrate (HMB) products on the short-term postoperative outcomes of minimally invasive esophagectomy for esophageal cancer. Altogether, 114 patients (Gln/Arg/HMB group) received perioperative nutritional therapy with Gln/Arg/HMB products, and we retrospectively investigated the change in nutritional parameters including skeletal muscle mass, occurrence of postoperative complications, and short-term postoperative outcomes in this group. The results were compared between the Gln/Arg/HMB and control groups (79 patients not receiving the Gln/Arg/HMB products). The incidence of all postoperative complications, sputum expectoration disorder, and pleural effusion of grade ≥ III was significantly lower in the Gln/Arg/HMB group (62.0% vs. 38.6%, p = 0.001; 44.3% vs. 28.1%, p = 0.020; 27.8% vs. 13.2%, p = 0.011, respectively). The psoas muscle area and postoperative body weight were significantly higher at 1 month and 1 year after surgery in the Gln/Arg/HMB group than in the control group (93.5% vs. 99.9%, p < 0.001; 92.0% vs. 95.4%, p = 0.006). Perioperative amino-acid-enriched nutritional therapy may improve the short-term postoperative outcomes, nutritional status, and skeletal muscle mass of esophageal cancer surgical patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General and Digestive Surgery, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinadamachi, Kahoku 920-0293, Ishikawa, Japan.
- Department of Gastrointestinal Surgery, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.
- Department of General and Digestive Surgery, Kanazawa Medical University Himi Municipal Hospital, Himi, Toyama 935-8531, Japan.
- Department of Surgery, Fukui Prefectural Hospital, 2-8-1 Yotsui, Fukui 910-0846, Japan.
ORCID-Profile: Koichi Okamoto, Daisuke Kaida, Takashi Miyata, Shinichi Kinami, Itasu Ninomiya
Zitieren
APA
Okamoto, K., Takamura, H., Nagayama, T., Sannomiya, Y., Hashimoto, A., Nishiki, H., Kaida, D., Miyata, T., Tsuji, T., Fujita, H., Kinami, S., Ninomiya, I., & Inaki, N. (2024). Usefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study. Nutrients, 16(13), 2126. https://doi.org/10.3390/nu16132126
Vancouver
Okamoto K, Takamura H, Nagayama T, Sannomiya Y, Hashimoto A, Nishiki H, et al. Usefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study. Nutrients. 2024;16(13):2126. doi:10.3390/nu16132126
BibTeX
@article{Okamoto2024,
author = {Okamoto, Koichi and Takamura, Hiroyuki and Nagayama, Taigo and Sannomiya, Yuta and Hashimoto, Akifumi and Nishiki, Hisashi and Kaida, Daisuke and Miyata, Takashi and Tsuji, Toshikatsu and Fujita, Hideto and Kinami, Shinichi and Ninomiya, Itasu and Inaki, Noriyuki},
title = {Usefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {13},
pages = {2126},
doi = {10.3390/nu16132126}
}
EUVIMED